2 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Michael Burke: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Blinatumomab Bridging Therapy for BALL Blinatumomab - B-cell Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia | Phase 2 | Terminated | Michael Burke | 2 | 2021-01-01 | 2025-05-13 |
| Epigenetic Reprogramming in Relapse AML Decitabine, Vorinostat, Fludarabine - Leukemia, Acute Myeloid | Phase 1 | Terminated | Michael Burke | 3 | 2015-02-21 | 2019-01-24 |
Burkitt Lymphoma (1) · Leukemia, Myeloid, Acute (1)
Cytarabine (1) · Decitabine (1) · Filgrastim (1) · Sorafenib (1) · Vorinostat (1) · blinatumomab (1) · fludarabine (1) · fludarabine phosphate (1)
United States (2)